These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Comparison of the efficacy of two air-based contrast agents in dogs.
    Author: Uchimoto R, Niwa K, Tsuda N, Miyazawa T, Bräutigam M.
    Journal: Eur J Ultrasound; 2000 May; 11(2):127-33. PubMed ID: 10781661.
    Abstract:
    OBJECTIVE: The aim of this study was to evaluate the differences of the in vivo efficacies of Levovist(SH U 508 A) and Albunex, air-based contrast agents (CAs) with different shell materials, by direct comparison. METHODS: SH U 508 A, 300 mg/ml, and Albunex were injected intravenously at doses of 0.1 and 0.15 ml/kg, respectively, into the same dogs (n=6). Contrast enhancement in the left ventricle was evaluated visually and by off-line measurement of brightness. RESULTS: Both CAs yielded good peak contrast, while the duration of contrast enhancement with SH U 508 A was seven times that with Albunex. With Albunex, reduction of contrast enhancement at end-systole and in the late phase of diastole during one heartbeat was observed, and a positive correlation was observed between contrast enhancement and heart rate. Contrast enhancement was nearly constant during one heartbeat with SH U 508 A. CONCLUSION: SH U 508 A yielded consistent and longer contrast enhancement in the left ventricle than Albunex under the same conditions.
    [Abstract] [Full Text] [Related] [New Search]